Pages that link to "Q44243674"
Jump to navigation
Jump to search
The following pages link to Olanzapine use as an adjunctive treatment for hospitalized children with anorexia nervosa: case reports (Q44243674):
Displaying 31 items.
- Towards the pharmacotherapy of eating disorders (Q28206098) (← links)
- World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders (Q28249390) (← links)
- Evaluation of the efficacy and safety of olanzapine as an adjunctive treatment for anorexia nervosa in adolescent females: a randomized, double-blind, placebo-controlled trial (Q33317432) (← links)
- Treatment of Adolescent Eating Disorders: Progress and Challenges (Q34877274) (← links)
- Olanzapine Use for the Adjunctive Treatment of Adolescents with Anorexia Nervosa (Q35036803) (← links)
- Challenges in conducting a multi‐site randomized clinical trial comparing treatments for adolescent anorexia nervosa (Q35118851) (← links)
- A double-blind, placebo-controlled study of risperidone for the treatment of adolescents and young adults with anorexia nervosa: a pilot study (Q35209098) (← links)
- New targets in the treatment of anorexia nervosa (Q36066305) (← links)
- The psychopharmacotherapy of anorexia nervosa: clinical, neuroendocrine and metabolic aspects (Q36068453) (← links)
- Emerging drugs for eating disorder treatment (Q36458423) (← links)
- Challenges associated with controlled psychopharmacological research trials in adolescents with eating disorders. (Q36468328) (← links)
- A review of medication use for children and adolescents with eating disorders (Q36468337) (← links)
- Differential weight restoration on olanzapine versus fluoxetine in identical twins with anorexia nervosa (Q36630151) (← links)
- Comorbidity of eating disorders with bipolar disorder and treatment implications (Q36677648) (← links)
- The role of olanzapine in the treatment of anorexia nervosa (Q36693209) (← links)
- Atypical antipsychotics in severe anorexia nervosa in children and adolescents--review and case reports (Q37000626) (← links)
- Medication management of pediatric eating disorders (Q37127455) (← links)
- What potential role is there for medication treatment in anorexia nervosa? (Q37236316) (← links)
- Pharmacologic and psychotherapeutic treatment of anorexia nervosa (Q37608392) (← links)
- Atypical antipsychotics and anorexia nervosa: a review (Q37669911) (← links)
- Psychopharmacology of Eating Disorders in Children and Adolescents (Q37833758) (← links)
- Early Onset Eating Disorders in Male Adolescents: A Series of 10 Inpatients (Q37955190) (← links)
- The safety of olanzapine in young children: a systematic review and meta-analysis. (Q38242011) (← links)
- Pharmacologic and Psychotherapeutic Treatment of Anorexia Nervosa (Q39177697) (← links)
- Aripiprazole in anorexia nervosa and low-weight bulimia nervosa: case reports (Q46208591) (← links)
- Olanzapine use in adolescent anorexia nervosa (Q48496003) (← links)
- Quetiapine in anorexia nervosa patients: an open label outpatient pilot study (Q50927580) (← links)
- Prescription of olanzapine in children and adolescent psychiatric patients (Q51979289) (← links)
- [Affective disorders and eating disorders] (Q86430234) (← links)
- Canadian practice guidelines for the treatment of children and adolescents with eating disorders (Q89539368) (← links)
- Evaluation of the Effectiveness and Safety of Olanzapine as an Adjunctive Treatment for Anorexia Nervosa in Adolescents: An Open-Label Trial (Q90430285) (← links)